AmacaThera, a clinical-stage biotechnology company specializing in drug delivery, announced it has signed a binding ...

Germany’s Merck KGaA has agreed to buy SpringWorks Therapeutics, adding the US biotech’s portfolio of cancer and rare disease ...

Germany's Merck KGaA has struck a deal to buy U.S. biotech company SpringWorks Therapeutics for an equity value of $3.9 ...

(Reuters) -U.S. drugmaker Merck is investing $1 billion in a new Delaware plant to expand its domestic production as it ...

FRANKFURT (REUTERS) -German healthcare and materials group Merck KGaA said on Monday it struck a deal to acquire U.S. biotech ...

Germany's Merck is on the verge of a billion-euro takeover of US biopharmaceutical company Springworks Therapeutics, with the ...

DelveInsight's "IBRANCE Market Size, Forecast, and Market Insight Report" highlights the details around IBRANCE, a CDK4/6 inhibitor. The ...

Tariff worries continue hanging over companies as they report their latest financial results and try to provide guidance on ...

The global Cell Based Assays Market, valued at US$17.29 billion in 2024, is forecasted to grow at a robust CAGR of 9.1%, reaching US$17.84 ...

Experts have raised concerns about a deadly virus which has already killed hundreds of rabbits in Europe. A strain of rabbit haemorrhagic disease (RHD) already seen in countries such as the ...

In many of Europe's social-welfare states, the political equivalent of the Liberal Party is merely a minority Coalition player, often lucky to win more than 15 per cent of the vote. Outside ...